[3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.

[3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.
复制标题

[3H]spiroxatrine 标记大鼠海马中的 5-羟色胺 1A 样位点。

DOI:
10.1016/0024-3205(87)90723-5
复制
发表时间:
1987
期刊:
影响因子:
6.1
通讯作者:
Yamamura,HI
Yamamura,HI
中科院分区:
医学2区
文献类型:
--
作者:
Nelson,DL;Monroe,PJ;Lambert,G;Yamamura,HI

文献摘要

被引文献

相似文献

[~ 3 H]Spiroxatrine作为一种潜在的配体标记大鼠海马5-HT_(1A)位点。在不存在和存在不同浓度的三种单胺神经递质的情况下,[3 H]螺沙丁胺的结合分析显示,5-羟色胺(5-HT)具有高亲和力([3 H]螺沙丁胺结合位点的IC 50 = 20.7 nM,与5-HT 1位点的标记一致),而多巴胺和去甲肾上腺素的亲和力非常低(IC 50 =57600 nM和>10− 4 M)。[3 H]spiroxatrine结合的饱和度研究揭示了一个单一的人口与Kd=2.21 nM的网站。使用5-HT 1阿立哌酮、8-羟基-2-(二正丙基氨基)四氢萘、伊沙匹龙和WB 4101以及丁酰苯化合物螺哌隆和氟哌啶醇进行进一步药理学表征,得到的结果与[3 H]螺唑嘌呤标记的5-HT 1 A位点一致。该配体产生稳定的、可再现的结合,具有良好的特异性与非特异性结合比率。[3 H]spiroxatrine的结合是敏感的GTP,这表明该配体可能作为一种激动剂。这一点得到了以下发现的支持:螺沙丁胺抑制大鼠海马中毛喉素刺激的腺苷酸环化酶活性(一种拟议的5-HT 1A受体模型)。由于[3 H]spiroxatrine在结构上不同于其他目前可用的5-HT 1Asite放射性配体,它应该提供新的信息,这种假定的肾上腺素能受体的属性。
[3H]Spiroxatrine was examined as a potential ligand for the labeling of 5-HT1Asites in the rat hippocampus. Analysis of the binding of [3H]spiroxatrine in the absence and presence of varying concentrations of three monoamine neurotransmitters revealed that serotonin (5-HT) had high affinity (IC50= 20.7 nM for the [3H]spiroxatrine binding sites, consistent with the labeling of 5-HT1sites, while dopamine and norepinephrine had very low affinity (IC50=57600 nM and >10−4M respectively). Saturation studies of the binding of [3H]spiroxatrine revealed a single population of sites with a Kd=2.21 nM. Further pharmacologic characterization with the 5-HT1Aligands 8-hydroxy-2-(di-n-propylamino) tetralin, ipsapirone, and WB4101 and the butyrophenone compounds spiperone and haloperidol gave results that were consistent with [3H]spiroxatrine labeling 5-HT1Asites. This ligand produced stable, reproducible binding with a good ratio of specific to nonspecific binding. The binding of [3H]spiroxatrine was sensitive to GTP, suggesting that this ligand may act as an agonist. This was supported by the finding that spiroxatrine inhibits forskolin-stimulated adenylate cyclase activity (a proposed 5-HT1Areceptor model) in the rat hippocampus. Since [3H]spiroxatrine is structurally distinct from other currently available radioligands for the 5-HT1Asite, it should provide new information about the properties of this putative serotonergic receptor.